Anna Wald

Title: Innovations by Anna Wald in HSV Research

Introduction

Anna Wald is a prominent inventor based in Seattle, WA (US), known for her significant contributions to the field of virology, particularly in the research and treatment of herpes simplex virus (HSV) infections. With a total of 2 patents, her work has paved the way for improved therapeutic strategies against HSV.

Latest Patents

Wald's latest patents include the invention titled "Antigenic peptide of HSV-2 and methods for using same." This invention provides HSV antigens that are useful for the prevention and treatment of HSV infection. It includes epitopes confirmed to be recognized by T-cells derived from herpetic lesions. T-cells that have specificity for the antigens of this invention have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against cells infected with HSV. The identification of immunogenic antigens responsible for T-cell specificity offers improved anti-viral therapeutic and prophylactic strategies. Compositions containing these antigens or polynucleotides encoding them provide effectively targeted vaccines for the prevention and treatment of HSV infection.

Career Highlights

Anna Wald has had a distinguished career, working with esteemed institutions such as the University of Washington and Fred Hutchinson Cancer Center. Her research has significantly advanced the understanding of HSV and its treatment options.

Collaborations

Wald has collaborated with notable colleagues, including Lawrence G. Corey and Kerry J. Laing, contributing to the collective effort in HSV research and treatment.

Conclusion

Anna Wald's innovative work in the field of HSV research exemplifies the impact of dedicated inventors in advancing medical science. Her patents and collaborations continue to influence the development of effective treatments for HSV infections.